Insulin Administration Guidelines.
Ozempic (for type 2 diabetes) is available in three pre-filled pen strengths in the US: 2 mg/1.5 mL pen (1.34 mg per mL) - delivers 0.25 mg or 0.5 mg doses 4 mg/3 mL pen (1.34 mg per mL) - delivers 1 mg doses 8 mg/3 mL pen (2.67 mg per mL) - delivers 2 mg doses Wegovy (for weight management) comes in single-dose pens with concentrations of 0.25 mg/0.5 mL (0.5 mg/mL), 0.5 mg/0.5 mL (1 mg/mL), 1 mg/0.5 mL (2 mg/mL), 1.7 mg/0.75 mL (2.27 mg/mL), and 2.4 mg/0.75 mL (3.2 mg/mL)

Non-pharmacological management strategies: Dietary modifications that may help manage GI symptoms include: Eat smaller, more frequent meals rather than large portions Avoid high-fat, greasy, or spicy foods that delay gastric emptying further Stay well-hydrated with small, frequent sips of water Avoid lying down immediately after eating (wait 23 hours) Identify and avoid personal trigger foods Eat slowly and chew thoroughly Lifestyle adjustments: Avoid strong odours that may trigger nausea Ensure adequate fresh air and ventilation Practice stress-reduction techniques, as anxiety can exacerbate nausea Maintain good sleep hygiene Alternative pharmacological options: If symptoms persist despite lifestyle measures, discuss these evidence-based alternatives with your prescriber: Antiemetics: Medications such as metoclopramide (short-term only), prochlorperazine, or cyclizine may be prescribed for persistent nausea

Tirzepatide: available and gaining ground Tirzepatide is FDA-approved as Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)
What is Sermorelin and how does it differ from HGH
Eli Lilly's orforglipron is an investigational once-daily oral small molecule GLP-1 that does not carry restrictions on food and water intake, while retatrutide is a first-in-class once-weekly triple hormone receptor agonist activating GIP, GLP-1, and glucagon receptors [2]